BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6339046)

  • 1. Inhibition of natural killer cell activity by a soluble substance released by rat peritoneal cells.
    Zighelboim J; Lichtenstein A; Bick A; Mickel R
    Cancer Res; 1983 May; 43(5):1984-9. PubMed ID: 6339046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
    Brunda MJ; Taramelli D; Holden HT; Varesio L
    J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer inhibitory substance produced by the peritoneal cells of patients with ovarian cancer.
    Lichtenstein AK; Berek J; Zighelboim J
    J Natl Cancer Inst; 1985 Feb; 74(2):349-55. PubMed ID: 3856049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic control of a retrovirus-associated murine adenocarcinoma. VIII. Corynebacterium parvum-activated natural killer cells as potent antibody-dependent cell-mediated cytotoxicity effectors.
    Weinhold KJ; Bolognesi DP; Matthews TJ
    J Natl Cancer Inst; 1985 Oct; 75(4):717-24. PubMed ID: 3862904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Corynebacterium parvum-induced suppressor cells of mouse NK and ADCC activity.
    Santoni A; Santoni G; Piccoli M; Herberman RB; Frati L
    Immunopharmacol Immunotoxicol; 1990; 12(3):363-87. PubMed ID: 2148342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pregnancy on augmentation of natural killer cell activity by Corynebacterium parvum and Toxoplasma gondii.
    Luft BJ; Remington JS
    J Immunol; 1984 May; 132(5):2375-80. PubMed ID: 6715884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine lymph node natural killer cells: regulatory mechanisms of activation or suppression.
    Hisano G; Hanna N
    J Natl Cancer Inst; 1982 Sep; 69(3):665-71. PubMed ID: 6180211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression and abrogation of suppression of induced nonspecific cytotoxicity against tumor cells.
    Egawa K; Tanino T
    Jpn J Exp Med; 1985 Aug; 55(4):143-53. PubMed ID: 2935654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro augmentation of rat natural killer (NK) cell activity.
    Reynolds CW; Herberman RB
    J Immunol; 1981 Apr; 126(4):1581-5. PubMed ID: 6451648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the mechanism of natural killer cell-mediated cytotoxicity. V. Lack of NK specificity at the level of induction of natural killer cytotoxic factors in cultures of human, murine, or rat effector cells stimulated with mycoplasma-free cell lines.
    Wright SC; Bonavida B
    J Immunol; 1984 Dec; 133(6):3415-23. PubMed ID: 6491292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of natural killer cell activity in mice by injection of indomethacin.
    Voth R; Chmielarczyk W; Storch E; Kirchner H
    Nat Immun Cell Growth Regul; 1986; 5(6):317-24. PubMed ID: 2432415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer cell number and function in the spontaneously diabetic BB/W rat.
    Woda BA; Biron CA
    J Immunol; 1986 Sep; 137(6):1860-6. PubMed ID: 3745917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
    Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of macrophage in in vitro augmentation of rat, mouse, and human natural killer activities.
    Reynolds CW; Brunda MJ; Holden HT; Herberman RB
    J Natl Cancer Inst; 1981 May; 66(5):837-42. PubMed ID: 6164813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of natural killer cell cytotoxicity by splenocytes from Corynebacterium parvum-injected, bone marrow-tolerant, and infant mice.
    Savary CA; Lotzová E
    J Immunol; 1978 Jan; 120(1):239-43. PubMed ID: 342602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local and systemic immune response to inactivated Candida albicans in mice.
    Scaringi L; Rosati E; Cornacchione P; Fettucciari K; Sabatini R; Biondi R; Mezzasoma L; Valiani M; D'Errico P; Marconi P
    Nat Immun; 1995 Sep; 14(5-6):234-49. PubMed ID: 8933818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of murine natural killer cell activity in vitro and in vivo by recombinant human interferons.
    Brunda MJ; Rosenbaum D
    Cancer Res; 1984 Feb; 44(2):597-601. PubMed ID: 6692364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F; Peri G; Villa A; Mantovani A
    J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of natural killer cell activity in spleens of infant, aged, and low responder strain mice by Corynebacterium parvum.
    Gallagher MT; Nasrallah AG; Datta SK; Priest EL; Trentin JJ
    Exp Hematol; 1981 Feb; 9(2):149-55. PubMed ID: 7238649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.